BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19584455)

  • 1. Heteroplasmy of mitochondrial D310 mononucleotide repeat region in the blood of patients with Alzheimer's disease.
    Wang PN; Lee HC; Wang CH; Ping YH; Liu TY; Chi CW; Lin KN; Liu HC
    J Alzheimers Dis; 2009; 18(2):345-53. PubMed ID: 19584455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer's brain.
    Chang SW; Zhang D; Chung HD; Zassenhaus HP
    Biochem Biophys Res Commun; 2000 Jun; 273(1):203-8. PubMed ID: 10873587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors.
    Sanchez-Cespedes M; Parrella P; Nomoto S; Cohen D; Xiao Y; Esteller M; Jeronimo C; Jordan RC; Nicol T; Koch WM; Schoenberg M; Mazzarelli P; Fazio VM; Sidransky D
    Cancer Res; 2001 Oct; 61(19):7015-9. PubMed ID: 11585726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
    Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
    Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment.
    Wang J; Markesbery WR; Lovell MA
    J Neurochem; 2006 Feb; 96(3):825-32. PubMed ID: 16405502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment.
    Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
    Free Radic Res; 2008 Feb; 42(2):162-70. PubMed ID: 18297609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing.
    Coon KD; Valla J; Szelinger S; Schneider LE; Niedzielko TL; Brown KM; Pearson JV; Halperin R; Dunckley T; Papassotiropoulos A; Caselli RJ; Reiman EM; Stephan DA
    Mitochondrion; 2006 Aug; 6(4):194-210. PubMed ID: 16920408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutation in mitochondrial DNA and nuclear microsatellite instability in gastric cancer.
    Hiyama T; Tanaka S; Shima H; Kose K; Tuncel H; Ito M; Kitadai Y; Sumii M; Yoshihara M; Shimamoto F; Haruma K; Chayama K
    Oncol Rep; 2003; 10(6):1837-41. PubMed ID: 14534705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low mutational burden of individual acquired mitochondrial DNA mutations in brain.
    Simon DK; Lin MT; Ahn CH; Liu GJ; Gibson GE; Beal MF; Johns DR
    Genomics; 2001 Apr; 73(1):113-6. PubMed ID: 11352572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease.
    Rombouts SA; Goekoop R; Stam CJ; Barkhof F; Scheltens P
    Neuroimage; 2005 Jul; 26(4):1078-85. PubMed ID: 15961047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
    Hernanz A; De la Fuente M; Navarro M; Frank A
    Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial microsatellite instability in colorectal carcinomas--frequency and association with nuclear microsatellite instability.
    Guleng G; Løvig T; Meling GI; Andersen SN; Rognum TO
    Cancer Lett; 2005 Feb; 219(1):97-103. PubMed ID: 15694669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.
    Jung SM; Lee K; Lee JW; Namkoong H; Kim HK; Kim S; Na HR; Ha SA; Kim JR; Ko J; Kim JW
    Neurosci Lett; 2008 May; 436(2):153-7. PubMed ID: 18378077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of retinal and blood mitochondrial DNA from age-related macular degeneration patients.
    Kenney MC; Atilano SR; Boyer D; Chwa M; Chak G; Chinichian S; Coskun P; Wallace DC; Nesburn AB; Udar NS
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4289-97. PubMed ID: 20357205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
    Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
    Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.
    Galimberti D; Fenoglio C; Lovati C; Venturelli E; Guidi I; Corrà B; Scalabrini D; Clerici F; Mariani C; Bresolin N; Scarpini E
    Neurobiol Aging; 2006 Dec; 27(12):1763-8. PubMed ID: 16307829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
    Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
    NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.